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Shanghai, ChinaBackground and Aims: The ERCP volume in developed countries has decreased recently, whereas the ERCP
trend is unknown in developing countries. This study aimed to evaluate the ERCP development in China between
2006 and 2012.
Methods: All hospitals performing ERCP in mainland China in 2012 participated in an online survey. Data
on ERCP infrastructure, volume, indication, and adverse events were collected and compared with those in a
previous national survey and in developed countries.
Results: From 2006 to 2012 the number of hospitals performing ERCP in China increased from 470 to 1156. The
total ERCP volume increased from 63,787 to 195,643, of which >95% were therapeutic. The ERCP rate in China
(14.4 per 100,000 inhabitants) in 2012 was still much lower than that in developed countries. There was signiﬁcant
imbalance between different regions (1.3-99.1 per 100,000 inhabitants). The median ERCP volume per hospital
decreased from 80 (interquartile range [IQR], 31-150) in 2006 to 52 (IQR, 20-146) in 2012. The median volume
of the 686 hospitals that started ERCP after 2006 was 31.5 (IQR, 11-82). The post-ERCP adverse event rate in 2012
was comparable between hospitals in terms of volume (500 or <500 per year: 5.8% vs 5.6%) and practice
durations (starting ERCP before or after 2006: 5.5% vs 5.6%).
Conclusions: ERCP has developed considerably in China in recent years. Despite low annual volume, the hos-
pitals starting ERCP after 2006 have acceptable adverse event rates and will be promising and important sources of
ERCP development in China. (Gastrointest Endosc 2016;84:659-66.)ERCP is an important technique for pancreaticobiliary
disease and has continued to develop for more than 4
decades.1,2 In developed countries, the role of ERCP has
gradually changed from a diagnostic to a therapeutic
modality, and the total volume has decreased in more
recent years.3-5 However, reliable data on the trend of
ERCP growth in developing countries are sparse, especially
in China, India, and other emerging market countries
where ERCP is still a relatively new and rising technique.ns: CSDE, Chinese Society of Digestive Endoscopy; GDP, gross
oduct; IQR, interquartile range.
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urnal.orgAccording to the national survey conducted by the Chi-
nese Society of Digestive Endoscopy (CSDE) in 2007, a to-
tal of 63,787 ERCP procedures were performed in 470
hospitals across mainland China in 2006, with an estimated
annual ERCP rate of 4.87 per 100,000 inhabitants,6 thereby
suggesting that ERCP use needs substantial improvement.
Recently, the economy of China has developed dramati-
cally. Thus, ERCP use may also be signiﬁcantly improved.
To address this issue, the CSDE conducted another surveyReceived January 21, 2016. Accepted March 8, 2016.
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TABLE 1. General status of hospitals providing ERCP in China in 2006
and 2012
2006
(n [ 470)
2012
(n [ 1156)
ERCP development in China Hu et alin 2013 to evaluate the development over 6 years and to
investigate the potential problems in ERCP use in China.
This study may also provide useful information for other
developing countries.Hospital grading
Tertiary referral hospitals 75.5 (339) 76.5 (884)
Secondary referral hospitals 24.5 (110) 22.7 (262)
Ungraded hospitals 0.0 (0) 0.9 (10)
Hospital ownership
Government-administered hospitals 47.7 (214) 52.2 (603)
University-affiliated hospitals 47.0 (211) 35.5 (410)
Military hospitals 4.0 (18) 6.6 (76)
Private or foreign-invested hospitals 1.3 (6) 5.8 (67)
Department performing ERCP
Department of Gastroenterology 68.6 (308) 68.0 (786)
Department of Endoscopy 16.3 (73) 26.9 (311)
Department of General Surgery 6.7 (30) 1.5 (17)
Other departments* 8.5 (38) 3.6 (42)
Owning established endoscopy unit 76.0 (341) 96.9 (1120)
Owning x-ray fluoroscopes
exclusive for ERCP
15.6 (70) 32.2 (372)
Values are percents, with total number of cases in parentheses.
*Such as the Department of Interventional Radiology or Oncology.METHODS
Conduct of the survey
The present study was initiated and organized by the
CSDE and supervised by the Chinese National Ministry of
Health as part of the Chinese Digestive Endoscopy Census
2012. All 31 provincial branches of the CSDE in mainland
China participated in the survey. Hospitals that could
provide ERCP service were conﬁrmed through local health
authorities by CSDE branches. Online predesigned struc-
tured questionnaires were completed by a senior endo-
scopist in each hospital. Data were collected by CSDE
headquarters and analyzed in Shanghai.
After returning the questionnaires to the organizer, 1 of
10 hospitals involved were selected through simple
random sampling. From November 2013 to February
2014 the involved individual branches of the CSDE
covering these selected hospitals collected the ofﬁcial
annual reports from the hospitals and independent
personnel of the CSDE branch checked the data on the
questionnaires and then returned the results to the orga-
nizer. If signiﬁcant discrepancies were present in the
data between 2 data sources, the questionnaire was
considered invalid and excluded in the analysis by the
organizer.
Contents of the questionnaire
The contents were completed according to the data in
2012. The questionnaire included data on the general sta-
tus of hospitals; infrastructure for ERCP; volume, indica-
tion, and anesthesia method for ERCP procedures; and
post-ERCP adverse events. The general status of hospitals
included hospital ownership and grading. In China the
Chinese Ministry of Health graded the hospitals as III,
II, and I, which is in descending order. Grades III and
II hospitals are tertiary and secondary referral hospitals,
respectively,6 and ERCP could be performed in these
hospitals. Post-ERCP adverse events in this survey
included post-ERCP pancreatitis, bleeding, perforation,
and cholangitis. The deﬁnition of adverse events was
consistent with Cotton et al’s ERCP adverse event
consensus.7
Data collection and analysis
Data from returned questionnaires were extracted and
summarized in a database for further analysis. The ERCP
rate in a year was used as a main index to evaluate the ad-
equacy of ERCP use. The gross domestic product (GDP)
per capita was used as the main index to represent the eco-
nomic development of a provincial region.8 The data in660 GASTROINTESTINAL ENDOSCOPY Volume 84, No. 4 : 2016this survey were compared with those retrieved or
estimated from the previous national survey in 2007 and
published reports from developed countries.3,7,9-15Statistical analysis
Categoric data are shown as percentages. The nonpara-
metric correlation statistical test (1-sided Spearman test)
was used to analyze the correlations between regional
GDP per capita and ERCP rate. The Student t test was
used to analyze the association between the adverse event
rate and an individual hospital’s ERCP volume or duration
of ERCP service. Simple random sampling and statistical
analyses were performed using SPSS version 17.0 for Win-
dows (SPSS Inc, Chicago, Ill). A 2-sided P < .05 was consid-
ered to be statistically signiﬁcant.RESULTS
General status and ERCP infrastructure of
hospitals
In 2012, 1156 hospitals performed ERCP in mainland
China, which was 2.46-fold the number in 2006 (n Z
470). All of these hospitals responded to this survey. The
data check was performed in 117 hospitals (10.1%), and
no check revealed signiﬁcant discrepancies in these
hospitals.
Table 1 lists the general status of these hospitals per-
forming ERCP. In the 1156 hospitals, more than halfwww.giejournal.org
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Figure 1. ERCP rates of China and developed countries.
Figure 2. Development of ERCP rate (the number of ERCP procedures per 100,000 inhabitants) in the 31 provincial regions of mainland China between
2006 and 2012 (Northeast: Heilongjiang, HL; Jilin, JL; Liaoning, LN. East: Beijing, BJ; Fujian, FJ; Guangdong, GD; Hainan, HaN; Hebei, HeB; Jiangsu, JS;
Shandong, SD; Shanghai, SH; Tianjin, TJ; Zhejiang, ZJ. Central: Anhui, AH; Henan, HeN; Hubei, HuB; Hunan, HuN; Jiangxi, JX; Shanxi, SX. West: Gansu,
GS; Guangxi, GX; Guizhou, GZ; Inner Mongolia, IM; Ningxia, NX; Qinghai, QH; Shaanxi, ShX; Sichuan, SC; Tibet, XZ; Xinjiang, XJ; Yunnan, YN; Chongq-
ing, CQ. Hong Kong, HK; Macau, MAC; Taiwan, TW). This map does not show the complete territory of China.
www.giejournal.org Volume 84, No. 4 : 2016 GASTROINTESTINAL ENDOSCOPY 661
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Figure 3. Scatter plot depicting the relationship between ERCP rate and GDP per capita in different regions of mainland China in 2006 and 2012
(blue points, 2006: rZ .871, P < .001; red points, 2012: rZ .452, PZ .005). Both the x- and y-axes of the graph have a different scale after the breaks
(// and \\) to include the information more compactly. See Figure 2 legend for the key to the abbreviations. GDP, gross domestic product.
ERCP development in China Hu et al(52.2%) were government-administered and most (76.5%)
were tertiary referral hospitals, which was similar to the sta-
tus in 2006. In 2012, 1120 hospitals (96.9%) providing
ERCP services had an established endoscopy unit, and
372 (32.2%) had x-ray ﬂuoroscopes owned by the endos-
copy unit, which was higher than the number in 2006.
Across mainland China, 85 hospitals provided ERCP in
the Northeast, 535 in the East, 229 in the Central, and
307 in the Western regions.
ERCP volume and its distribution
In 2012 the total ERCP volume in mainland China was
195,643, with an estimated ERCP rate of 14.4 per 100,000
inhabitants. The ERCP rate in 2012 was signiﬁcantly
increased from that in 2006 (4.9 per 100,000 inhabitants)
but was still much lower than the rates of developed coun-
tries (Fig. 1).
The development of ERCP rates in various regions be-
tween 2006 and 2012 is presented in Figure 2. Signiﬁcant
imbalance still existed in the regional distribution of662 GASTROINTESTINAL ENDOSCOPY Volume 84, No. 4 : 2016ERCP use in 2012, but the ERCP rate increase was more
obvious in the less-developed Western (4.34-fold) and Cen-
tral (3.14-fold) regions. A signiﬁcant correlation existed be-
tween the ERCP rate and GDP per capita in 2006 and 2012
(2006: r Z .871, P < .001; 2012: r Z .452, P Z .005)
(Fig. 3).
Signiﬁcant variation was observed in the annual ERCP
volume between different hospitals (Fig. 4). In 2006 the
median ERCP volume in each hospital was 80 (range,
2-1303; interquartile range [IQR], 31-150), and 29.1% of
hospitals performed fewer than 50 ERCPs throughout
the year, whereas in 2012 the median ERCP volume
decreased to 52 (range, 1-3478; IQR, 20-146), and
46.8% of hospitals performed fewer than 50 ERCPs
throughout the year. Among the 686 hospitals that
started ERCP after 2006, the median ERCP volume in
2012 was 31.5 (range, 1-1000; IQR, 11-82). In 2012,
262 secondary referral hospitals performed 7.8% of all
procedures (15,188/159,966), and the median annual
ERCP volume was 25 (range, 1-422; IQR, 11-55).www.giejournal.org
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Figure 4. Distribution of different-level hospitals with different ERCP volumes. The 10 ungraded centers were not included in this ﬁgure, and their
median ERCP volume in 2012 was 36.5.
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Figure 5. ERCP indication in China between 2006 and 2012.
Hu et al ERCP development in ChinaIndication and adverse events
In 2006 and 2012, the proportions of therapeutic ERCP
were 95.2% and 96.9%, respectively. The detailed ERCP
indication is shown in Figure 5. In both 2006 and 2012,
cholelithiasis was the most common indication. Overall,
47,643 ERCP procedures (24.4%) were performed with
the patient under conscious sedation in 644 hospitals
(55.7%) in 2012.
In 2012 the reported post-ERCP adverse events in China
included 8471 (4.33%), 1016 (.52%), 352 (.18%), and 1285
(.66%) cases with post-ERCP pancreatitis, bleeding, perfo-
ration, and cholangitis, respectively. The adverse event
rate was similar between high-volume (500/y) and low-
volume (<500/y) hospitals and between hospitals thatwww.giejournal.orgstarted ERCP before or in 2006 and hospitals that started
ERCP after 2006 (Table 2).DISCUSSION
This is the ﬁrst report about nationwide ERCP develop-
ment from a developing country. The overall ERCP use
improved signiﬁcantly in China between 2006 and 2012,
with the annual ERCP rate almost tripled. However, the ab-
solute volume of ERCPs still needs to be substantially
increased in China compared with developed countries.
Low-volume hospitals constituted a considerable propor-
tion, especially for hospitals that started ERCP after 2006.Volume 84, No. 4 : 2016 GASTROINTESTINAL ENDOSCOPY 663
TABLE 2. Reported post-ERCP adverse events from Chinese hospitals in 2012
Adverse
event
Overall
(%)
Hospitals with
volume ≥ 500/y
(n [ 65)
Hospitals with
volume <500/y
(n [ 1091) P value
Hospitals that started
ERCP before or during
2006 (n [ 470)
Hospitals that started
ERCP after 2006
(n [ 686) P value
Pancreatitis 4.33 4.65 4.18 .26 4.23 4.73 .35
Bleeding .52 .38 .59 .08 .51 .59 .12
Perforation .18 .23 .16 .09 .18 .16 .30
Cholangitis .66 .69 .64 .54 .59 .64 .55
Total 5.69 5.79 5.64 .43 5.51 5.64 .40
ERCP development in China Hu et alNevertheless, the adverse event rates in those hospitals
were acceptable, and these emerging ERCP providers
may offer a feasible solution for China’s large demand for
ERCP.
ERCP is an important technique for the diagnosis and
treatment of pancreaticobiliary diseases. Because CT,
MRCP, and other imaging modalities partly replaced
ERCP as a diagnostic tool, temporal changes in ERCP vol-
ume have been observed in many countries in more recent
years, and the total volume has decreased in some devel-
oped countries.3-5 However, this phenomenon may not
be the reality in developing countries. In China, India,
Brazil, and other rising developing countries, ERCP is still
at the early development stage with rapid growth along
with the economy. There are large-volume ERCP centers
in some developed regions, managing patients transferred
from the entire country and training ERCP practitioners
for less-developed regions.16-18 Therefore, there may be
different patterns in ERCP use, practice status, and quality
control compared with developed countries.
From 2006 to 2012, ERCP use in China has seen consid-
erable improvement. The total number of hospitals per-
forming ERCP increased from 470 to 1156, and the
annual ERCP rate increased from 4.9 to 14.4 per 100,000 in-
habitants. The development trend of ERCP in China today
is fairly different from that in developed countries but is
consistent with the economic growth and increase of med-
ical input in China, which promoted both the renewal of
ERCP infrastructure and the training of ERCP practitioners.
Compared with common digestive endoscopy, ERCP
needs relatively more human and material resources, and
economic factors inﬂuence its use to a large extent. As
shown in this study, a signiﬁcant association exists between
the ERCP rate and the local GDP per capita (P < .05). From
2006 to 2012 the GDP per capita of China increased from
$2083 to $6264, and the health expenditure per capita
increased from $94 to $326,8 both of which are parallel
with the growth of the ERCP rate. More and more hospitals
have established endoscopy units and exclusive x-ray ﬂuo-
roscopes. Meanwhile, the total number of ERCP practi-
tioners in China increased from 1155 (.88 per million) to
3345 (2.47 per million).19 This is mainly because standard
ERCP training programs have been widely conducted in
China’s large endoscopy centers, and more continuing664 GASTROINTESTINAL ENDOSCOPY Volume 84, No. 4 : 2016medical education programs, including academic confer-
ences and endoscopy workshops, are now available.
Although the ERCP development in China is inspiring,
the following 3 aspects should be considered further. First,
the absolute volume of ERCP procedures still needs to be
substantially increased. To date, there is no consensus on
the optimal ERCP rate for a country, but the ERCP rates
of developed countries can be adopted as suboptimal ref-
erences, which basically ranged within 70 to 100 per
100,000 inhabitants, almost 5-fold that of China in 2012
(Fig. 2). Furthermore, China is a region with a high preva-
lence of pancreaticobiliary diseases.20-24 The ERCP rates of
developed countries may not be the benchmark for China
in the recent period, but the signiﬁcant shortage in less-
developed and remote regions instigated our concern in
this area. The most developed region in China, Shanghai,
had an ERCP rate of 99.1 per 100,000 inhabitants, which
was comparable with that in developed countries. Mean-
while, the ERCP rate in Tibet was only 1.3 per 1,000,000 in-
habitants. Moreover, the total ERCP volume in 262
secondary referral hospitals, most of which were located
in small and medium-sized towns, only constituted 7.8%
(n Z 15,188) of all procedures. Although this distribution
seemed reasonable to some extent during the early devel-
opment stage of a technique, with an expected narrowing
gap as the economy developed (Fig. 2), some measures
could be taken currently to alleviate this shortage and
maximize the beneﬁts of ERCP. We believe that patients
with indications for elective and challenging ERCP proce-
dures could be transferred to high-level hospitals in devel-
oped regions, whereas patients who need emergency
ERCP (eg, acute cholangitis) should be managed in the
local community hospital. Therefore, we suggest that
health authorities, especially in less-developed and remote
regions, should consider some targeted measures, such as
promoting multisite practice by experienced ERCP practi-
tioners and establishing ERCP centers mainly for emergen-
cies and procedures with low difﬁculty.
Second, the proportion of hospitals with low-volume
ERCP was high. In 2012 nearly half of the hospitals
(46.8%) performed fewer than 50 ERCPs throughout the
year. This result could be attributed mainly to the 686 hos-
pitals that started ERCP after 2006, most of which were
located in less-developed and remote regions. The medianwww.giejournal.org
Hu et al ERCP development in ChinaERCP volume of these 686 hospitals in 2012 was only 31.5
(range, 1-1000; IQR, 11-82). Although the hospitals with
low-volume ERCP have been a concern for a long
time,10,12,25-28 we still consider these hospitals as a feasible
solution for the large demand for ERCP in China in recent
years. On one hand, encouraging hospitals and endoscop-
ists to start an ERCP service is necessary for ERCP develop-
ment, especially in less-developed regions, even though
their volume may not be high in the beginning. On the
other hand, the adverse event rate did not signiﬁcantly in-
crease in these hospitals, suggesting an acceptable quality
of procedures. The association between the ERCP volume
of a hospital and the quality and outcome of ERCP has not
been conclusive. Several studies showed that only if the en-
doscopists are technically competent and the indication is
appropriate, low-volume hospitals could also complete
ERCPs with high success rates and low adverse event
rates.12,28 In fact, most hospitals with low ERCP volumes
(or during the initial years after starting ERCP) would select
patients who required low-difﬁculty procedures and would
invite experienced ERCP practitioners from large ERCP
centers to guide or live-demonstrate procedures, both of
which are beneﬁcial for increasing ERCP quality. In our
opinion, balancing quality improvement and quantity in-
crease has been a difﬁcult problem for a long time in the
development of China’s healthcare system, because the
gap has always been large but human and material re-
sources are limited. Seemingly low-level modiﬁcations,
such as barefoot doctors (farmers who received basic med-
ical and paramedical training and worked in rural villages)
decades ago, may also be a feasible method.29 Therefore,
we recommend that these low-volume hospitals should
continue their ERCP service but should manage patients
with appropriate indications and risk levels according to
the practice status.
Third, a number of large ERCP centers have emerged.
During the past decade, a large number of hospitals in
China experienced a new round of rapid expansion. In
2012, 20 top ERCP centers completed 20% of the total vol-
ume in China (individual ERCP volume, 1069-3478). These
centers have become the main referral centers and training
centers for ERCP and completed most studies and practice
guidelines on ERCP in China.30-32 However, the core prin-
ciple of healthcare reform in China is to provide basic
health care as a “public service” to the people; healthcare
facilities at the community level are the priority for ﬁnan-
cial input.33 Considering that ERCP is a challenging and
important technique, we still believe that these large
ERCP centers need continuous support in developing
personnel and increasing ERCP volume to lead ERCP devel-
opment nationwide in the future.
This study has several limitations. First, this study is
retrospective, and recall bias could not be avoided. A na-
tional prospective survey or registry is necessary for subse-
quent study. Second, this study is the ﬁrst online national
survey on digestive endoscopy in mainland China, andwww.giejournal.orgsome data, such as detailed indication, anesthesia methods,
and successful rate of cannulation, were not included,
which precluded further analysis about the quality control.
In conclusion, ERCP has developed considerably in
China in recent years. Although most have low annual vol-
umes, the hospitals starting ERCP after 2006 have accept-
able adverse event rates and will be the essential growth
point for ERCP development in China, which should be
the priority for support in the future.
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